- Home
- NXL vs CLEU Comparison
NXL vs CLEU Comparison
Compare NXL & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- CLEU
- Stock Information
- Founded
- NXL 2010
- CLEU 2011
- Country
- NXL United States
- CLEU China
- Employees
- NXL N/A
- CLEU N/A
- Industry
- NXL Medical Specialities
- CLEU Other Consumer Services
- Sector
- NXL Health Care
- CLEU Real Estate
- Exchange
- NXL Nasdaq
- CLEU Nasdaq
- Market Cap
- NXL 24.2M
- CLEU 20.0M
- IPO Year
- NXL 2022
- CLEU 2020
- Fundamental
- Price
- NXL $1.15
- CLEU $1.92
- Analyst Decision
- NXL Strong Buy
- CLEU
- Analyst Count
- NXL 1
- CLEU 0
- Target Price
- NXL $5.00
- CLEU N/A
- AVG Volume (30 Days)
- NXL 121.2K
- CLEU 34.5K
- Earning Date
- NXL 05-20-2025
- CLEU 01-01-0001
- Dividend Yield
- NXL N/A
- CLEU N/A
- EPS Growth
- NXL N/A
- CLEU N/A
- EPS
- NXL N/A
- CLEU N/A
- Revenue
- NXL $168,721.00
- CLEU $2,413,409.00
- Revenue This Year
- NXL $79.59
- CLEU N/A
- Revenue Next Year
- NXL $334.65
- CLEU N/A
- P/E Ratio
- NXL N/A
- CLEU N/A
- Revenue Growth
- NXL 52.35
- CLEU N/A
- 52 Week Low
- NXL $0.53
- CLEU $0.05
- 52 Week High
- NXL $4.49
- CLEU $7.90
- Technical
- Relative Strength Index (RSI)
- NXL 22.27
- CLEU 53.23
- Support Level
- NXL $1.75
- CLEU $1.82
- Resistance Level
- NXL $1.39
- CLEU $1.95
- Average True Range (ATR)
- NXL 0.13
- CLEU 0.13
- MACD
- NXL -0.05
- CLEU 0.01
- Stochastic Oscillator
- NXL 0.01
- CLEU 70.59
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.